Senior Director, Vonjo, Core Asset Team (CAT) Lead
Core
Define and execute global strategy for Sobi's Vonjo portfolio, including label expansion in myelofibrosis and development of the VEXAS indication.
Role type
Senior Director, Global Asset Strategy Lead
Builds
Global development and commercialization programs for rare disease assets
Domain
Biopharmaceuticals, Hematology/Rheumatology, Rare Diseases
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work -> product features (indication expansion, lifecycle management)
Required skills
Global asset strategy, lifecycle management, cross-functional leadership, regulatory readiness, evidence generation planning, market access strategy, budget management, risk mitigation
Preferred skills
Science background, experience in hematology/rheumatology, experience in US/Europe/Middle East/LATAM markets, fluency in English
Technologies
None stated
Responsibilities
Define global asset strategy for Vonjo; Develop Integrated Project Plan (IPP) with resourcing and budget; Lead lifecycle management (LCM) and label expansion; Shape global program architecture for VEXAS indication; Align evidence generation plans with asset strategy; Assess ex-U.S. markets for geographic expansion; Build investment cases and manage budgets; Represent asset in executive portfolio reviews; Coordinate cross-functional teams (R&D, Medical, Commercial, Regulatory)
Seniority
Senior Director, strategic leadership